Evidence map›Paper›PMID 36671373›Full record

ArticleAntibiotics (Basel, Switzerland)2023

Burden of Hospitalizations Related to Pneumococcal Infection in Spain (2016-2020).

Ruth Gil-Prieto, Nizar Allouch, Isabel Jimeno, Valentín Hernández-Barrera, Raquel Arguedas-Sanz, Ángel Gil-de-Miguel

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. [Pneumococcal meningitis in a tertiary care hospital: clinical characteristics, serotype distribution, and vaccination status].Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Ruth Gil-PrietoPreventive Medicine and Public Health, Rey Juan Carlos University, 28922 Madrid, Spain.ORCID 0000-0002-5229-3832
Nizar AllouchPreventive Medicine and Public Health, Rey Juan Carlos University, 28922 Madrid, Spain.
Isabel JimenoPrimary Care Health Center Isla de Oza, Vaccine Responsible of SEMG, 28035 Madrid, Spain.
Valentín Hernández-BarreraPreventive Medicine and Public Health, Rey Juan Carlos University, 28922 Madrid, Spain.
Raquel Arguedas-SanzDepartment of Business Economics and Accounting, Universidad Nacional de Educación a Distancia UNED, 28004 Madrid, Spain.ORCID 0000-0001-7368-6347
Ángel Gil-de-MiguelPreventive Medicine and Public Health, Rey Juan Carlos University, 28922 Madrid, Spain.ORCID 0000-0003-1295-7101
Universidad Rey Juan Carlos · ESMadrid Health Service · ESUniversidad Nacional de Educación a Distancia · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pneumococcal infection strongly contributes to morbidity and mortality in Spain. A total of 253,899 hospitalizations related to pneumococcal infection occurred from 2016 to 2020. Fifty-eight percent were men, the mean age was 67 years old, and the average length of hospitalization was 12.72 days. The annual hospitalization rate was 10.84 hospitalizations per 10,000 population, increasing significantly with age, reaching 65.75 per 10,000 population in those aged >85 years. The hospitalization rates for pneumococcal pneumonia, sepsis, and meningitis were 2.91, 0.12, and 0.08 hospitalizations per 10,000, respectively, and reached the highest value in those aged >85 for pneumococcal pneumonia and sepsis, with 22.29 and 0.71 hospitalizations per 10,000, respectively, and in children up to 1 year old for pneumococcal meningitis, with 0.33 hospitalizations per 10,000. The total number of deaths during the study period was 35,716, with a case-fatality rate of 14.07%. For pneumococcal pneumonia, sepsis, and meningitis, the case-fatality rates were 8.47%, 23.71%, and 9.99%, respectively. The case-fatality rate increased with age and did not vary by sex. The annual cost of these hospitalizations was more than EUR 359 million. There is therefore a high burden of disease and mortality caused by pneumococcal infection in our country, especially in elderly individuals.

Indexed as

epidemiologyhospitalizationspneumococcal infectionpneumococcal pneumonia

Identifiers

PMID36671373
PMCPMC9854580
OpenAlexW4316466087

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.